oncolytic virus therapies

Related by string. * oncolytics . Oncolytics . Oncolytic : PRN Oncolytics Biotech . Oncolytics TSX ONC . Oncolytics Biotech Inc. . oncolytic adenovirus / VIRUS . Virus . Viru : bird flu virus . hepatitis C virus HCV . H#N# influenza virus . swine flu virus / THERAPIES . Therapies . Therapie : vaccines biologic therapies . biologic therapies . regenerative medicine therapies . stem cell therapies * *

Related by context. All words. (Click for frequent words.) 81 platforms GVAX 81 GVAX ® 79 vaccines oncolytic virus 79 Crofelemer budesonide foam 79 R MSCRAMM 79 Veronate R 79 antiangiogenesis therapies 78 personalized cellular immunotherapy 78 TRANSDUR ® 78 product platforms GVAX 78 Initiates Enrollment 78 rheumatoid arthritis thrombocytopenia 77 MKC# MT 77 telomerase therapeutic 77 tumor activated prodrug 77 pentadentate logo R 77 include Healive 77 pralatrexate injection folate analogue 77 TRANSDUR ™ 76 Xcytrin R 76 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 76 candidates Azedra TM 76 HuCAL PLATINUM ® CysDisplay 76 MSCRAMM ® 76 Staphylococcus aureus Immune Globulin 76 R Saizen R 76 inflammatory autoimmune diseases 76 Zorbtive TM 76 ELADUR ™ 76 Ovitrelle R Serostim 76 products MKC# PP 76 topically applied SEPA 75 FUSILEV ® 75 Aurexis R 75 overactive bladder VANTAS R 75 HYVISC ® treatment 75 Completes Patient Enrollment 75 kidney urologic 75 GVAX R 75 PRN FDA Approves 75 Solazed TM 75 Provectus Pharmaceuticals specializes 75 Immunotherapeutic 75 Atridox R Atrisorb 75 Luveris R Ovidrel R 75 gastro intestinal inflammation 75 erlotinib Tarceva R 75 HuMax TAC 75 recombinant biopharmaceutical 75 include Altastaph TM 75 modified glutathione analog 75 product Fentanyl TAIFUN 75 delivery polymer matrix 75 HPV cervical dysplasia 75 Initiates Clinical Trial 75 sapacitabine CYC# 75 individualized cellular immunotherapy 75 include Alferon N 75 treats acute lymphoblastic 75 MCSP respectively 74 Zemiva TM 74 Amgen Neulasta R 74 Selective Electrochemical Tumor Ablation 74 XL# anticancer compounds 74 cosmetic cosmeceutical products 74 TRACON Pharmaceuticals 74 Initiates Phase II 74 markets HP Acthar 74 FDA APPROVES 74 Empatic ™ 74 MKC# MKC# PP 74 accumulate preferentially 74 TFChem licenses 74 CYT# potent vascular disrupting 74 agonistic human 74 Pruvel TM 74 Alseres Cethrin 74 HuMax 74 Prodarsan R 74 Telik logo TELINTRA 74 targeted radiotherapeutic 74 LymphoStat B TM 74 methylnaltrexone bromide 74 AAG geldanamycin analog 74 cancer immunotherapies 74 product platforms AZX# 74 Naglazyme R 74 SPL# Gel vaginal microbicide 74 Medarex logo 74 Personalized Immunotherapy 74 POSIDUR TM ELADUR TM 74 investigational immunotherapy 74 Cardium Therapeutics TM 74 using Crucell PER.C6 74 novel therapeutic antibodies 74 equine osteoarthritis marketed 74 Intravenous Human 74 oral proteasome inhibitor 74 candidates Azedra 74 lead molecular radiotherapeutic 74 include PLX IBD 74 aldehyde dehydrogenase ALDH2 deficiency 74 targeting Inflammatory Bowel 74 formerly LymphoStat B 73 treat male hypogonadism 73 Zicam Cold Remedy RapidMelts 73 IMPACS R 73 Receives Orphan Drug Designation 73 anti botulism antibody 73 CysDisplay R 73 Atrisorb D R 73 MOVIPREP R 73 Nicotine Conjugate Vaccine 73 ® ZEVALIN 73 R DepoCyt 73 SinuNase ™ 73 particularly SANCTURA XR 73 Hemispherx flagship products 73 fluorinated carbohydrate mimics 73 ZFP Therapeutics 73 recurrent metastatic ovarian cancer 73 PORxin TM platforms 73 ATRA IV 73 Panzem R 73 HuCAL GOLD R 73 Begins Dosing 73 ® bortezomib 73 CD# CEA 73 label Lipofen R 73 MKC# 73 IMPDH inhibitor 73 lintuzumab SGN 73 hypoxia activated prodrug 73 acyclovir Lauriad R 73 interferon beta 1a infertility 73 palonosetron hydrochloride Injection Dacogen 73 Submits Biologics License Application 73 ALTROPANE R 73 including eniluracil ADH 73 molecular imaging radiopharmaceutical 73 NEBIDO VANTAS SUPPRELIN LA 73 Bilive R combined 73 SinuNase TM 73 novel VDA molecule 73 ThermoDox ® clinical 73 R sorafenib tablets 73 sodium thiosulfate STS 73 ALN PCS 72 TNFerade TM 72 THR beta agonist 72 com BlackSingles.com R 72 FOLOTYN ® 72 novel L DOS# 72 acetonide FA 72 Reports Preclinical Data 72 Phase #b/#a clinical 72 Evoltra ® 72 Alfacell proprietary ribonuclease 72 rxRNA 72 rusalatide acetate 72 R Abelcet 72 targeted immunotherapies 72 Zicam Cold Remedy Chewables 72 Initiates Clinical 72 brand ciclesonide HFA 72 BiovaxID TM 72 erlotinib Tarceva ® 72 IgG1 monoclonal antibody 72 IMiDs ® 72 Presents Preclinical Data 72 signal averaging electrocardiography 72 NASH Huntington 72 Therapeutic Competitors Companies 72 COPEGUS R 72 humanized therapeutic 72 R metformin Concor 72 overactive bladder VANTAS 72 Unigene nasal calcitonin 72 Multiple Sclerosis Rheumatoid Arthritis 72 oral prodrug 72 clinical trials Archexin 72 LymphoStat B belimumab 72 IMiDs R 72 candidate XP# 72 refractory chronic lymphocytic 72 Peyronie disease Frozen Shoulder 72 Submits NDA 72 Initiate Clinical Trial 72 CCR9 antagonist 72 include ColorectAlert TM 72 candidate HuCNS SC 72 pharmacogenomic translational research 72 Kosan dependence 72 SUPPRELIN R LA 72 R bisoprolol Euthyrox 72 Copegus R 72 acetylgalactosamine 6 72 Zemiva TM Trofex TM 72 Receives Approvable Letter 72 Archexin 72 VISICOL R 72 ELADUR TM 72 dimebon latrepirdine 72 PANVAC VF 72 fibrosis IPF 72 novel immunotherapies 72 investigational monoclonal antibody 72 P#X# antagonist 72 DELATESTRYL R 72 PNP inhibitor 72 Ceragenin ™ 72 Endotoxin Activity Assay 72 Vaccine Adjuvant 72 evaluating picoplatin 72 Adagen ® 72 Fludara ® 72 HepeX B TM 72 Shigatoxin producing E. coli 72 IMiDs ® compound 72 Phase 2b Clinical Trial 72 Through Glycoscience R 72 Budesonide foam crofelemer 71 tivozanib AV 71 Myocet 71 BCG refractory carcinoma 71 TRIOLEX HE# APOPTONE HE# 71 mertansine 71 addressing idiopathic pulmonary 71 prostate cancer antigen prostatic 71 SPRYCEL ® 71 Generx TM 71 Empatic TM 71 candidate AQ4N 71 NicVAX TM 71 oral ghrelin agonist 71 delivers fluocinolone acetonide FA 71 Kuvan R 71 psoriasis rheumatoid arthritis 71 novel emulsion formulation 71 Disease IBD 71 SIX RO ROG 71 Combivir Kivexa 71 Trastuzumab DM1 71 Solazed ™ 71 ADCC enhanced 71 Phase 2b Trial 71 candidate deforolimus 71 Liprotamase 71 include Healive TM 71 Albugon 71 Symbioscience WISDOM PANEL 71 Epratuzumab 71 B Anflu R 71 JAK2 Inhibitor 71 MEK Inhibitor 71 Combination REOLYSIN R 71 Numoisyn R 71 HuMax Wnt 71 ovarian cancer chronic hepatitis 71 infectious diseases autoimmune diseases 71 nilotinib Tasigna 71 TRAIL receptor antibodies 71 proprietary BiTE ® 71 Restoraderm R 71 vapreotide acetate 71 XP# XP# 71 TURNING INSIGHTS INTO HOPE 71 Onalta TM 71 IG HCR ;) CO 71 Xcellerated T Cells 71 TM Aganocide 71 investigational pharmacologically unique 71 next generation URAT1 71 pan histone deacetylase 71 Hsp# Inhibitor 71 docetaxel Taxotere R 71 Meets Primary Endpoint 71 highly purified pasteurized 71 OncoVex 71 NOTE POSIDUR ™ 71 AFREZZA TM 71 Peginterferon alfa 2b 71 vaccine GRNVAC1 71 Locked Nucleic Acid 71 colorectal bladder 71 please visit www.abraxane.com 71 attach auristatin 71 ZEVALIN ® 71 Cell Genesys GVAX 71 technology visit http:/www.genmab.com 71 Inc. AMEX YMI 71 sorafenib tablets 71 VEGFR2 inhibitor 71 ® EBLY ® MASTERFOODS 71 oral nucleoside analogue 71 Aganocide 71 treat lupus renal 71 TRIOLEX ™ 71 monoclonal antibody IgG1 Mab 71 MassARRAY R 71 NUVIGIL ® 71 using VIAdel TM 71 Surfaxin LS 71 HuCAL GOLD ® 71 ® PLEDGE 71 vinorelbine tartrate 71 5 lipoxygenase activating 71 ALVESCO ® 71 TNFerade ™ 71 Vitrasert R 71 evaluating Actimmune 71 Clolar ® 71 non porcine pancreatic 71 telomerase inhibitor drug 71 Receives Milestone Payment 71 Adnectin 71 LungAlert TM 71 HuMax CD#b 71 Namenda Memantine HCl 71 Launches Generic Version 71 trastuzumab DM1 T DM1 71 molecular therapeutics immunotherapies 71 triggers apoptosis programmed 71 ENABLE Phase 2 71 oral picoplatin 71 candidate Gabapentin GR 71 MEDAREX 71 Through Glycoscience 71 bucindolol hydrochloride 71 Romiplostim 71 Merck OSI Pharmaceuticals 71 Wafer polifeprosan 70 antibody MAb 70 RapMAT ® 70 memantine HCl 70 Daclizumab 70 external counterpulsation systems 70 Inovio clinical 70 HIV AIDS neuropathic pain 70 Zemiva ™ 70 based pretargeting methods 70 Custirsen 70 HyperAcute 70 StaphVAX R 70 Aganocide ® 70 HCD# [002] 70 lexidronam injection 70 DepoCyt ® Abelcet ® 70 HPV cervical cancer 70 candidate CRLX# 70 Xcellerex FlexFactory 70 selective immunoproteasome inhibitor 70 Aflibercept 70 Other ImmunoGen collaborative 70 HuCAL PLATINUM R 70 PI3K/Akt pathway inhibitor 70 Mylan Receives Approval 70 cetuximab Erbitux R 70 BHT DNA 70 HEPLISAV TM hepatitis B 70 unique PER.C6 70 MSCRAMM R 70 Achieves Primary Endpoint 70 Protexia ® 70 Vidaza R 70 Teva Provides Update 70 Cytogen marketed 70 Asentar ™ 70 Alferon LDO 70 IMA# 70 legendary SPACE INVADERS 70 motexafin gadolinium Injection 70 commercializing oxidized glutathione 70 2 inhibitor CYT# 70 syndrome overactive bladder 70 Micromet proprietary BiTE 70 DG# compounds targeting 70 Merck Serono Nycomed 70 SYCREST 70 candidate TNFerade biologic 70 dasatinib Sprycel ® 70 include GALNS N 70 Initiates Phase III 70 Files IND 70 TELINTRA 70 signal detection CTSD 70 ® lenalidomide 70 metastatic colorectal 70 ALN HPN 70 markets COLAZAL 70 platinum chemotherapeutic 70 Bifunctional Muscarinic Antagonist Beta2 70 apricitabine ATC 70 BEMA ® 70 Pancreas Cancer Vaccine 70 Nventa proprietary CoVal 70 TRIOLEX HE# 70 rheumatoid arthritis Roche PEGASYS 70 MT#/MEDI-# 70 therapy Tovaxin 70 includes TOLAMBA TM 70 SuperAntibody 70 dasatinib Sprycel 70 GlaxoSmithKline MedImmune 70 IV Busulfex 70 RANK Ligand inhibitor 70 Gel repository corticotropin injection 70 UltiMAb TM 70 Dyax logo 70 Bayer HealthCare Onyx Pharmaceuticals 70 Agonist MABA program 70 Inc. www.micromet inc.com 70 progressive metastatic prostate 70 developing ACAPODENE 70 CRM# Protein 70 prescription brands RESTYLANE 70 trial evaluating OrCel 70 Eg5 kinesin spindle 70 Aradigm Logo 70 lucinactant 70 DARA logo 70 Receives Orphan Drug 70 Staphylococcus aureus Polysaccharide Conjugate 70 ASE SVA 70 Hematology Molecular Pathology 70 ESpy TM 70 INTEGRILIN R eptifibatide Injection 70 commercializing anti infective 70 XL# XL# 70 t2cure GmbH 70 HeartMate ® 70 dermatology therapies 70 utilizes InSite Vision 70 Elagolix 70 Valortim TM 70 Cobalamin TM mediated 70 INSPIRE Trial Phase III 70 platform HDL Mimetic 70 Marqibo TM 70 include ClindaReach TM 70 HGS ETR1 mapatumumab 70 milnacipran HCl 70 DosePro TM 70 4SC AG ISIN DE# 70 treat refractory angina 70 targeted antifolate 70 Shows Promise Against 70 Initiates Dosing 70 essential thrombocythemia ET 70 Exelixis compounds 70 Quinamed R 70 Generx ® 70 TELINTRA R 70 Genentech sanofi aventis 70 Gene Expression RAGE 70 Completes Enrollment 70 DNA methyltransferase inhibitors 70 Elotuzumab 70 cutaneous T 70 targeted anticancer biopharmaceuticals 70 Therapeutic Vaccine 70 Canvaxin TM 70 imatinib Gleevec ® 70 NovaDel oral spray 70 ImmunoGen TAP technology 70 Earns Milestone Payment 70 RNAi Therapeutic 70 tiapamil 70 Tramiprosate ALZHEMED TM 70 polysaccharide polymer 70 immunotherapeutic agent 70 tenofovir disoproxil fumarate Viread 70 Nanoemulsion 70 novel histone deacetylase 70 candidate MyVax 70 dihydrochloride Tablets 70 catheter occlusion 70 abobotulinumtoxinA 70 molecular chaperone regulation 70 R Rituximab Herceptin 70 purinergic receptors P#X# 70 Copegus ® 70 XL# XL# XL# XL# 70 orally administered inhibitor 70 HCl PEPCID ® famotidine 70 CDK cyclin dependent 69 sarcoma melanoma 69 ocular formulation 69 successfully commercialize Iluvien 69 5 lipoxygenase inhibitor 69 Advancing Drugs 69 SATURA ® 69 R bortezomib 69 budesonide MMX ® 69 Gonal f R 69 personalized dendritic 69 ® SHOWTIME FAMILYZONE 69 Xolegel Vusion 69 NEBIDO R 69 arsenic trioxide injection 69 R lenalidomide 69 rheumatoid arthritis inflammatory bowel 69 PORxin TM 69 introduced NEUGENE 69 Successfully Completes Phase 69 product candidate Lpathomab 69 orally inhaled migraine 69 PEG SN# 69 Additionally Soligenix 69 YONDELIS 69 HQK 69 Resurgex Plus R 69 Oracea TM 69 vaginally administered lidocaine 69 SHRED MATRIX ® 69 First Patient Dosed 69 Tibotec Therapeutics division 69 trastuzumab Herceptin R 69 Affinity Optimized Antibody 69 LPLD Hemophilia B 69 MICRODUR TM 69 Antigenics QS 69 endoscopic autofluorescence imaging 69 Cerashield ™ 69 triciribine phosphate monohydrate 69 Panzem R NCD 69 commercialize CorMedix drug 69 Tarmogen 69 milnacipran HCI 69 diarrhea predominant irritable 69 Submits Response 69 Sciences ABthrax Albuferon 69 COLAZAL R 69 ABLYNX 69 interferon alpha IFN 69 commercializes oncology 69 IMiDs 69 USP Tablets PEPCID 69 intravesical infusion therapy 69 Prochymal TM 69 TNF Tumor Necrosis Factor 69 PREVENAR 69 corticotropin injection 69 cardiometabolic diseases Glucophage 69 5 HT3 antagonist 69 aesthetic medicine BioLook 69 BENLYSTA TM 69 non personalized allogeneic 69 initiated Phase 1b 69 PROSTASCINT R 69 Nipent R 69 GTC recombinant human 69 Onalta ™ 69 Angiocept 69 Belimumab 69 Demonstrates Significant 69 Acetavance TM intravenous acetaminophen 69 Locked Nucleic Acid LNA 69 R SHOWTIME FAMILYZONE 69 Nasdaq HALO biopharmaceutical 69 RIGScan TM CR 69 hereditary emphysema 69 R memantine HCl 69 POTELLIGENT ® 69 novel nucleoside analog 69 www.vivus.com 69 aerosolized AAT 69 Boehringer Ingelheim MedImmune 69 tramiprosate Alzhemed TM 69 Taiho Pharmaceutical 69 CYCLOSET ® 69 sodium Injection 69 developing ostarine selective 69 products Oncaspar ® 69 Alvine Pharmaceuticals 69 S. Arzerra 69 PF # [002] 69 hypereosinophilic syndrome 69 RECOTHROM ® 69 PMX # heptagonist 69 Ostabolin C TM 69 candidate REP# 69 leading oral taxane 69 5 fluorouracil leucovorin 69 neuropathic pain metabolic diseases 69 PDE4 inhibitor 69 equine osteoarthritis 69 R famotidine 69 R vitespen 69 TOCOSOL Camptothecin 69 UltiMAb ® 69 TransVax ™ 69 ionotropic glutamate receptor antagonists 69 serine protease inhibitor CU# 69 volociximab 69 R Bortezomib 69 BiTE R 69 alfimeprase direct 69 Nutra Pharma wholly owned 69 indications Cytokinetics 69 RELOVAIR ™ 69 visit http:/www.mannkindcorp.com 69 panitumumab Vectibix 69 Arno Therapeutics 69 sirtuin inhibitor program 69 Lipid Polymer Micelle LPM 69 generation radiolabeled antibody 69 R rilonacept Injection 69 FS Antihemophilic Factor Recombinant 69 Novel Oral 69 NS5b 69 Selzentry Celsentri 69 HuCNS SC ® 69 gastrointestinal stromal 69 Mg Usa 69 NovaBay Aganocide 69 OvaRex R 69 NeuroSTAT ® 69 Ridaforolimus 69 DGAT1 inhibitors 69 Tetanus Toxoid Reduced Diphtheria 69 MAGE A3 ASCI 69 'S ® DOLMIO 69 cancer indications bafetinib 69 Nanobody R 69 vinca alkaloid 69 Receives Fast Track 69 armodafinil Tablets C 69 Granted Orphan Drug 69 Product candidate Serada 69 TMC xtra 69 novel proprietary KL4 69 deCODE ProstateCancer TM 69 Completes Dosing 69 Awarded Qualifying Therapeutic 69 Exherin 69 Presents Positive 69 sapropterin dihydrochloride Tablets 69 StromaCel Inc. 69 prokinetic agent 69 regarding Aethlon Medical 69 OTC BB PVCT 69 acid phosphatase PAP 69 Annamycin 69 lupus hepatitis C 69 pipeline ImmunoGen collaborators 69 Kit CD# positive 69 virus HCV protease inhibitor 69 delta opioid receptor 69 Oragens R 69 Navelbine ® 69 Severe Sepsis 69 IL# PE#QQR 69 DNA RNA Medicines 69 MyVax R 69 Thiarabine 69 INxin TM 69 * olmesartan medoxomil 69 Alferon N Injection 69 Healthy Eating Made Easier 69 AVEO Pharmaceuticals NASDAQ 69 developing Surfactant Replacement 69 temsirolimus Torisel 69 VisionDirect.com TM 69 Zalypsis 69 Aloprim TM allopurinol sodium 69 Patients Treated With 69 Toddler Thin Strips Decongestant 69 myocardial infarction ventricular fibrillation 69 Vicinium TM 69 atopic dermatitis neonatal 69 novel orally inhaled 69 Quinamed 69 candidate epratuzumab 69 DPX Survivac 69 mGluR5 negative 69 Essence Ultra LifePak 69 commercializing therapeutic 69 humanized interleukin 6 69 AzaSite TM 69 GRNOPC1 contains 69 OTCBB PYTO 69 oritavancin semi 69 PrevOnco ™ 69 LUNESTA ® 69 rotavirus shingles 69 Amgen Bayer Schering 69 ALN TTR 69 Aeolus Pharmaceuticals Announces 69 ONCASPAR 69 hepatitis C lupus 69 Roferon 69 Aerosurf 69 Pain Neutralizer holds 69 include VALSTAR TM 69 topical gel formulation 69 DIFICID ™ 69 HuMax TF 69 FOLFOX6 chemotherapy regimen 69 cyclobenzaprine hydrochloride extended 69 oral calcitonin licensed 69 GlycoPEGylated hemostasis compounds 69 nasal calcitonin product 69 selective kinase inhibitor 69 DUROS 69 anti CD3 monoclonal 69 developing Bicifadine serotonin 69 Femring ® 69 Neulasta R 69 Dural Regeneration Matrix 69 Chimigen TM 69 HCV Protease Inhibitor 69 compound KOS 69 Nasdaq MNKD focused 69 herpetic keratitis 69 www.syntapharma.com 69 Factor VIIa 69 anti idiotype 69 solid tumors ZYBRESTAT 69 targets Galectin receptors 69 AstraZeneca PLC Arimidex 69 docetaxel Taxotere ® 69 QUADRAMET R 69 including Random Activation 69 Vicriviroc 69 BUPHENYL R 69 * Azixa 69 immunotherapeutic approaches 69 romazarit 68 Cleviprex TM clevidipine 68 Albuferon albinterferon alfa 2b 68 visit www.genmab.com 68 Vitaxin 68 novel anti infective 68 Intermezzo ® zolpidem tartrate 68 DURECT proprietary 68 PDX pralatrexate 68 oral dual endothelin 68 Opterone R 68 Kuvan TM sapropterin 68 Announces Poster Presentations 68 Genasense ® oblimersen 68 cytomegalovirus immune globulin 68 visit www.genenews.com 68 cell carcinoma RCC 68 Serostim ® 68 Pegloticase 68 Glufosfamide 68 novel antimitotic agent 68 beta 1a 68 proprietary polysaccharide 68 AzaSite Xtra 68 http:/www.celgene.com 68 topical agent Xantryl 68 Therapeutic Competitors Report 68 pulmonology portfolio 68 VANTAS ® 68 novel antibody therapeutics 68 Emergent marketed 68 CoTherix logo 68 Phase III Pivotal 68 sapropterin dihydrochloride 68 HuLuc# 68 Oral NKTR 68 muscarinic receptor agonist 68 enhanced skin permeation 68 Storage Made Simple 68 METOZOLV TM ODT metoclopramide 68 Tibotec BVBA 68 AdVac ® 68 Romidepsin 68 selective androgen receptor modulators 68 Demonstrates Sustained 68 Azmacort R 68 Amgen Neulasta ® 68 HCl Tablets 68 Delta opioid receptor 68 Xeloda ® 68 R BorderGuard 68 Antibody Drug Conjugate 68 GLP1 INT TM 68 Bazedoxifene 68 ZFP Therapeutic ® 68 Zolpimist ™ 68 NPC 1C 68 phenylalanine ammonia lyase 68 intranasal vaccines derived 68 diagnostic molecular imaging 68 sodium benzoate prescription 68 NYSE Amex NBY clinical 68 Announces Tentative Approval 68 PDE4 modulators 68 drug pipeline TAFA# 68 Cetuximab Erbitux 68 proven DuraSite ® 68 knee joints Deflux 68 Silodosin 68 Inhalation Aerosol 68 Warfarin Coumadin 68 Announce License Agreement 68 Phase 2a Clinical Trial 68 ChromoCure develops 68 Panflu TM 68 MassARRAY ® 68 Vasomedical enhanced 68 selectively inhibit replication 68 KNS # 68 Aloxi ® 68 seliciclib CYC# 68 Surfactant Replacement Therapies SRT 68 patented Bioral 68 REPRONEX R menotropins 68 Therapeutic Competitors companiesandmarkets.com adEgemonye 68 www.ucb group.com 68 apomorphine hydrochloride 68 refractory gout 68 world safest multivalent 68 substantially excreted 68 2 methoxyestradiol 68 recombinant PSMA vaccine 68 Epigenomics proprietary 68 non nucleoside HCV 68 advanced metastatic renal 68 valtorcitabine 68 TransVax 68 Roche Boniva 68 researches develops licenses 68 indolent follicular non 68 NuMimetic TM 68 Regeneron Pharma 68 Advicor R 68 Demonstrates Potential 68 NICE Recommends 68 Receives CE Marking 68 orally bioavailable mimics 68 CTAP# Capsules 68 Viagra Soft Cialis Soft 68 Humanized Anti 68 Augment TM 68 hc2 High Risk 68 HCV polymerase 68 Enhanze 68 ONCONASE R 68 nilotinib Tasigna ® 68 tizanidine hydrochloride short 68 Inhalation Solution 68 Campto 68 induced mucositis 68 Rigel R# 68 www.telik.com 68 Sirenza logo 68 FDA Accepts 68 candidates bavituximab 68 produces Chrysler Jeep 68 doxercalciferol 68 GVAX cancer 68 Inc Therapeutic Competitors 68 Besivance 68 NurOwn 68 intranasal insulin product 68 evaluating bafetinib 68 DOXIL R 68 commercialize becocalcidiol patented 68 drugs FUSILEV 68 Allovectin 7 68 www.cellgenesys.com 68 investigational humanized monoclonal antibody 68 Nanobody 68 hyaluronidase enzyme 68 By JAMAAL ABDUL 68 Swiss Medica flagship 68 topical antifungal product 68 SABER ™ 68 gastric pancreatic 68 deCODE AF TM 68 AN# topical anti 68 VentiRx Pharmaceuticals 68 gefitinib Iressa 68 Vitrasert ® 68 anti infective ophthalmic 68 Invasive pneumococcal disease 68 Pertuzumab 68 hypertension osteoarthritis 68 Drug Candidate 68 Receives Positive Opinion 68 Phase IIb Trial 68 Azedra TM Onalta TM 68 PEGylated docetaxel 68 Adagen R 68 Pentad TM 68 manufactures minimally invasive 68 vaginal candidiasis 68 Recombinant Human 68 Emtriva Viread 68 metaglidasen 68 evaluating tivozanib 68 myasthenia gravis Huntington 68 Homspera TM 68 hormone LHRH antagonist 68 oral dihydropyrimidine dehydrogenase DPD 68 Vitamin D analogue 68 OTCBB URGP specialty 68 cervical breast 68 overactive bladder AA# 68 Onalta 68 Neutrolin ® 68 Presents Preclinical 68 FULL IMPACT 68 Factor Receptor 68 commercialize deforolimus 68 Adjuvant Treatment 68 product BioThrax ® 68 malignant infectious 68 sapropterin dihydrochloride Phase 68 mocetinostat MGCD# 68 active AKT inhibitor 68 counter brand ESOTERICA 68 Gonal f R follitropin 68 XmAb 68 AcryMed technologies 68 please visit http:/www.vandapharma.com 68 diagnostic radiopharmaceutical 68 AVASTIN 68 Mg Uk 68 damage cirrhosis liver 68 proteasome inhibitor 68 Ixempra 68 ULTRIO 68 DVT prophylaxis cholesterol 68 basal cell carcinoma squamous 68 Perflubutane Polymer Microspheres 68 receptor inhibiting monoclonal 68 selective angiogenic kinase inhibitor 68 Nasdaq IMGN 68 Potelligent Technology 68 drugstore.com TM Beauty.com 68 peptibody 68 relapsed leukemia 68 Tezampanel 68 chimeric monoclonal antibody 68 NYSE Amex PBTH 68 proprietary radiolabeled monoclonal 68 lung pancreatic 68 Janis Joplin soundalike respiratory 68 NASDAQ MNKD focuses 68 PATHFINDER ® TRACER 68 non nucleoside inhibitor 68 Inc. Nasdaq MITI 68 thalidomide Thalomid 68 therapeutic monoclonal antibody 68 Didronel 68 Prolongs Survival 68 phase III isavuconazole 68 HuMax HepC 68 neuro inflammatory 68 R bendamustine hydrochloride 68 intranasal formulation 68 secretory phospholipase A2 68 chemosensitizer 68 recombinant hepatitis B 68 develop HBV reactivation 68 DXL TM 68 R vancomycin hydrochloride 68 HP Acthar R 68 Mixing System RenalPure 68 Parkinson disease monogenic diseases 68 http:/www.vivus.com 68 Licenses Novel 68 AVAX AC Vaccine 68 HCV RNA polymerase 68 Interferon Alpha 68 R armodafinil Tablets 68 diabetes irritable bowel 68 Tarceva TM 68 subsidiaries visit http:/www.apricusbio.com 68 Tarvacin Anti Cancer 68 ACTIQ ® 68 reslizumab 68 PROMUS R 68 peptidic compound 68 PEGylated interferon 68 plus Copegus 68 synthetic lipoglycopeptide antibiotic 68 forodesine 68 alvespimycin 68 Enrolls First 68 proprietary PEGylation 68 Avoderm ® 68 systemic RNAi therapeutic 68 vitreoretinal disorders 68 UCB www.ucb group.com 68 ALVESCO R 68 Savella ® 68 Epeius Biotechnologies Corporation 68 Pruvel ™ 68 purified inactivated vaccine 68 Uracyst R Test 68 Angiotensin Converting Enzyme 68 Campath ®

Back to home page